Burjeel Holdings PLC, an ADX-listed super-specialty healthcare services provider, recently announced a joint venture partnership with Keralty S.A.S., a multinational health organization based in Colombia. The agreement aims to create a joint venture named Al Kalma, with the goal of promoting access to high-quality healthcare at an affordable cost. Al Kalma, which means ‘united for health and well-being’, will offer a unique value-based healthcare model with specialized primary care centers, health risk management, and integrated mental health services, targeting nearly 30 million patients over the next decade. The joint venture will be operated through a newly formed holding company in the Abu Dhabi Global Market jurisdiction, with both Burjeel Holdings and Keralty holding an equal 50% shareholding.
The strategic partnership between Burjeel Holdings and Keralty combines the expertise of both organizations for a rapid rollout in the Middle East, with potential expansion into North Africa. The joint venture will launch in Saudi Arabia, capitalizing on the country’s shift towards a primary healthcare model. The collaboration aims to extend services internationally by evaluating market opportunities and executing strategies on a country-by-country basis. Keralty, with nearly five decades of experience and operations in nine countries, offers a healthcare model focused on prevention, detection, and management of health risks, while Burjeel Holdings specializes in highly complex and specialized services across the Middle East.
The joint venture partnership announcement ceremony was attended by senior officials from Burjeel Holdings and Keralty, along with the UAE ambassador to Colombia. Joseba Grajales, President of Keralty, expressed enthusiasm for extending their healthcare model to new regions through the partnership with Burjeel Holdings. Grajales highlighted the success of their healthcare model in multiple countries, emphasizing the importance of understanding the health, social, and community needs of their patients. Dr. Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings, emphasized the partnership as a significant milestone in providing better health for diverse populations. Vayalil outlined the comprehensive well-being approach of their model, aiming to prevent, control, and care for diseases to enhance patient outcomes on a personalized level.
The partnership between Burjeel Holdings and Keralty signifies a strategic alliance that leverages the strengths of both organizations to offer high-quality healthcare services in the Middle East and potentially beyond. By combining their expertise and resources, the joint venture aims to address the evolving healthcare needs of populations in various markets, starting with Saudi Arabia. With a focus on prevention, detection, and management of health risks, as well as specialized services, Al Kalma seeks to reach a significant number of patients over the next decade while promoting access to affordable healthcare. The partnership underscores a commitment to improving health outcomes and well-being through innovation and collaboration in the healthcare industry.
Through the joint venture, Al Kalma, Burjeel Holdings and Keralty aim to create a unique healthcare model that prioritizes comprehensive well-being and personalized care. The partnership will focus on expanding services to new regions, starting with Saudi Arabia and potentially extending to North Africa. By leveraging their combined experience and expertise, the two organizations seek to provide high-quality healthcare services that meet the evolving needs of populations in different markets. The joint venture signifies a commitment to enhancing health outcomes, promoting access to affordable healthcare, and driving innovation in the provision of healthcare services. The partnership between Burjeel Holdings and Keralty represents a significant step towards achieving these goals and improving the health and well-being of millions of individuals.
